Maze Therapeutics, Inc. (MAZE)
45.03
+1.08
(+2.46%)
USD |
NASDAQ |
Feb 06, 16:00
45.06
+0.04
(+0.08%)
After-Hours: 20:00
Maze Therapeutics SG&A Expense (TTM) : 31.47M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| CDT Equity, Inc. | 14.67M |
| LENZ Therapeutics, Inc. | 60.86M |
| Liminatus Pharma, Inc. | 2.342M |
| Oruka Therapeutics, Inc. | 19.44M |
| MapLight Therapeutics, Inc. | 8.221M |